Drug · DIN 02509121
REDESCA
MULTIDOSE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 9, 2021; first marketed April 9, 2021.
- Drug Identification Number (DIN)
- 02509121
- Company (DIN owner)
- Shenzhen Techdow Pharmaceutical Co., Ltd.Shenzhen City, China
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous; Intravenous
- Therapeutic class (ATC)
- Enoxaparin B01AB05
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ENOXAPARIN SODIUM | 300 MG | 3 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 7, 2020: NOC 24766New Drug Submission (NDS)
Other DINs named REDESCA
- DIN 02509075 · Marketed
- DIN 02509083 · Marketed
- DIN 02509091 · Marketed
- DIN 02509105 · Marketed
- DIN 02509113 · Marketed